Reduction of calprotectin and phosphate during testosterone therapy in aging men: a randomized controlled trial
ConclusionCompared to the placebo group, 6 months of testosterone therapy (gel) reduced calprotectin and phosphate levels suggesting decreased inflammation and decreased cardiovascular risk.
Source: Journal of Endocrinological Investigation - Category: Endocrinology Source Type: research
More News: Advertising | Calcium | Cardiology | Cardiovascular | Endocrinology | Heart | Hormones | Study | Training | Universities & Medical Training